4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000128
Chairperson & CEO sold 9,500 shares at an average $517.71 ($4,918,273)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-08-25 | Sale : show line 2 in the form 10b5-1 | −2,029 | $516.12 | $1,047,205 | 331,914 | I |
| 2026-08-25 | Sale : show line 3 in the form 10b5-1 | −2,332 | $516.95 | $1,205,518 | 329,582 | I |
| 2026-08-25 | Sale : show line 4 in the form 10b5-1 | −2,004 | $518.08 | $1,038,238 | 327,578 | I |
| 2026-08-25 | Sale : show line 5 in the form 10b5-1 | −2,387 | $518.80 | $1,238,375 | 325,191 | I |
| 2026-08-25 | Sale : show line 6 in the form 10b5-1 | −668 | $519.91 | $347,297 | 324,523 | I |
| 2026-08-25 | Sale : show line 7 in the form 10b5-1 | −80 | $520.50 | $41,640 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $517.71 · $4,918,273 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-25 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −9,500 | 65,910 | I |
Loading xslF345X06/primarydocument.xml…